Concurrent chemoradiation with weekly cisplatin and daily capecitabine followed by intracavitary brachytherapy in the management of advanced cervical cancers.

In developing countries most of the cervical cancer presents in advanced stage of disease Improving the therapeutic outcome of bulky cervical cancers is a big challenge addition of newer chemotherapeutic agents, to increase the cure rates of bulky cervical cancers In the study patients with younger age , good performance status with IIIB disease had better response rate as they were able to complete CCRT schedule with manageable toxicities